- Home
- DYN vs SEM Comparison
DYN vs SEM Comparison
Compare DYN & SEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- SEM
- Stock Information
- Founded
- DYN 1984
- SEM 1996
- Country
- DYN United States
- SEM United States
- Employees
- DYN N/A
- SEM N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- SEM Hospital/Nursing Management
- Sector
- DYN Health Care
- SEM Health Care
- Exchange
- DYN Nasdaq
- SEM Nasdaq
- Market Cap
- DYN 1.9B
- SEM 1.6B
- IPO Year
- DYN 2020
- SEM 2009
- Fundamental
- Price
- DYN $22.76
- SEM $13.11
- Analyst Decision
- DYN Strong Buy
- SEM Buy
- Analyst Count
- DYN 14
- SEM 4
- Target Price
- DYN $34.93
- SEM $16.33
- AVG Volume (30 Days)
- DYN 2.9M
- SEM 1.3M
- Earning Date
- DYN 10-28-2025
- SEM 10-30-2025
- Dividend Yield
- DYN N/A
- SEM 1.76%
- EPS Growth
- DYN N/A
- SEM N/A
- EPS
- DYN N/A
- SEM 0.89
- Revenue
- DYN N/A
- SEM $4,879,122,000.00
- Revenue This Year
- DYN N/A
- SEM $4.99
- Revenue Next Year
- DYN N/A
- SEM $5.07
- P/E Ratio
- DYN N/A
- SEM $15.93
- Revenue Growth
- DYN N/A
- SEM 16.59
- 52 Week Low
- DYN $6.36
- SEM $11.65
- 52 Week High
- DYN $35.68
- SEM $40.98
- Technical
- Relative Strength Index (RSI)
- DYN 74.02
- SEM 42.47
- Support Level
- DYN $23.05
- SEM $13.94
- Resistance Level
- DYN $25.00
- SEM $14.67
- Average True Range (ATR)
- DYN 1.00
- SEM 0.45
- MACD
- DYN 0.72
- SEM -0.04
- Stochastic Oscillator
- DYN 78.19
- SEM 9.12
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About SEM Select Medical Holdings Corporation
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.